Gertrud Rey

Preliminary phase I/II results of ChAdOx1 SARS-CoV-2 vaccine

by Gertrud U. Rey On July 20, 2020, Oxford University’s Jenner Institute and the pharmaceutical company AstraZeneca reported preliminary results from phase I/II clinical trials assessing the safety and efficacy of a vaccine candidate against SARS-CoV-2.  The vaccine candidate, named AZD1222 (referred to in the publication as ChAdOx1 nCoV-19), consists of an adenovirus vector with an …

Preliminary phase I/II results of ChAdOx1 SARS-CoV-2 vaccine Read More »

The role of children in transmission of SARS-CoV-2

by Gertrud U. Rey It is well established that children experience less severe disease after infection with SARS-CoV-2. However, to what extent infected children contribute to transmission of the virus is less clear. This topic is of great interest as we prepare for the start of a new school year.  Are children less susceptible to infection …

The role of children in transmission of SARS-CoV-2 Read More »

The perfect storm

by Gertrud U. Rey A small subset of people are more vulnerable to severe complications and death resulting from SARS-CoV-2 infection. What causes this vulnerability? An increasing body of evidence suggests that patients suffering from severe COVID-19 often have one or more pre-existing conditions (co-morbidities). In an effort to describe the co-morbidities of COVID-19 patients …

The perfect storm Read More »

Scroll to Top